🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Simon Leedham Holly Eggington Sarah Blagden Massive congratulations for an excellent thesis and viva, Holly! Really enjoyed it. Another graduate from the prominent Prof Leedhams lab.

Check out Cancer Research UK's video! #TikTok vm.tiktok.com/ZGdYPMQeF/

💡 Obesity is not a behavior. It’s time we stop pretending it is and start treating it with the evidence, compassion, and care it deserves. Science wins over blame every time. #TakeThatToTheBankMAHA

I am very excited that registration for #PrevConf25 has opened and folks are already signing up. The amazing 2025 conference co-chairs Sarah Blagden, Marc Gunter (Imperial) & Dr. Elizabeth Jaffee are pulling together an exciting agenda. I am already looking forward to the new year!

Accelerating the Future of Oncology Drug Development: The Role of Consortia in the Delivery of Precision Oncology Early Phase Clinical Trials buff.ly/3WhU2gL The landscape of early phase clinical trials (EPCTs) has expanded dramatically over the past 15 years, with a

"We now know that cancer does not come from nowhere." Prof Sarah Blagden, director of a new research collaboration between pharma giant GSK and the University of Oxford, tells #R4Today about the development of a new 'pre-cancer' vaccine that could target the disease earlier.

'This partnership represents a step forward in cancer research.' Professor Irene Tracey comments on the launch of a new £50million immuno-prevention collaboration between University of Oxford and GSK to advance novel cancer research. 👇 cancer.ox.ac.uk/news/oxford-an…

Oxford and GSK launch £50million immuno-prevention programme to advance novel cancer research — Oxford Cancer cancer.ox.ac.uk/news/oxford-an…

Detective work and persistence are critical factors to Dr Natalie Cook unlocking the secrets to some of the world's most challenging cancers. #WorldCancerDay

📢 Meet the co-chairs of #PrevConf25! We’re excited to have Sarah Blagden (University of Oxford), Marc Gunter (Imperial College London) and Dr. Elizabeth Jaffee (Johns Hopkins University) leading this year’s Cancer Prevention Research Conference. They’ll be guiding a packed agenda filled with cutting-edge

One day course on Cancer Prevention London 24th. With Phil Castle & Eva Szabo National Cancer Institute Sarah Blagden Walid Khaled Hayden McRobbie and others CRUKCOLcentre eventbrite.co.uk/e/learn-the-ba…

Celebrating International Women's Day 2025 oncology.ox.ac.uk/blog/celebrati….

The MILI trial is pleased to announce that our 7th site, University Hospitals of Leicester NHS Trust, is now open to recruitment! Leicester's Hospitals The George Pantziarka TP53 Trust #TP53 #LiFraumeniSyndrome #LFS

Integrating PPI has been transformative in many unexpected ways. The main surprise is how it motivates our own trial staff. A win-win.

The integration of prevention into the delivery of primary care is essential if we are to achieve a more holistic and effective approach to patient well-being. It means shifting the focus of care beyond just treating immediate illnesses to proactively safeguarding future health.

It was a great pleasure to present at #iDR25 - especially about #LiFraumeniSyndrome and the MILI trial - linking drug repurposing as a way to reduce cancer incidence in a genetic predisposition. Thank you to all at REMEDi4ALL for a fantastic conference

Lots of conversation and networking at our event exploring preventative cancer vaccines St Anne's College Oxford Cancer